CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Pharmion

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

May 19, 2004

Acquired by Celgene → Bristol-Myers Squibb on Jan 1, 2007

Timeline

2000s

Jan 1, 2000
Pharmion— Founded
May 19, 2004
azacitidine— NDA Organization
Jan 1, 2007
Celgene— Acquired By

2010s

Jan 3, 2019
Bristol-Myers Squibb— Now

Indications

Approved for

Marketed drugs (1)

azacitidine

Details

Founded: Boulder, CO, US Jan 1, 2000
First NDA: May 19, 2004
Last known activity: May 19, 2004

Designations held

Orphan drug
Fast track
Priority review

Notes

Acquired by Celgene